PFE

Recent Articles

5 Blue-Chip Stocks to Sell for December

These five stocks to sell appear to be likely losers for December thanks to garbage charts and a weak history in a historically robust month. More 

Eli Lilly and Co (LLY) Drug Failure Doesn’t Answer the Bigger Question

Eli Lilly (LLY) may be a bargain after today's plunge, but LLY stock won't be a good Alzheimer's bet anytime in the foreseeable future. More 

Cloud M&A: Oracle Corporation (ORCL) to Buy DNS Provider Dyn

Oracle Corporation (ORCL) is planning to purchase DNS provider Dyn in an effort to reduce load times and speed up service for its customers. More 

17 Pharmaceuticals Stocks to Sell Now

This week, the ratings of 17 Pharmaceuticals stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

The 10 Best Pharma Stocks Under President Donald Trump

The world was shocked by Donald Trump's surprise victory, but few equities will benefit as much as big pharma stocks. More 

26 Pharmaceuticals Stocks to Sell Now

The ratings of 26 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

The 7 Best Dividend Stocks to Buy for 2017

A new year and new president make some dividend stocks look like total return champions for 2017, including ABBV, WFC, GE and much more. More